Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2013 - 2026)
Enanta Pharmaceuticals' Asset Utilization Ratio was 0.21 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 2.7% from 0.21 a year earlier but down 0.7% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Asset Utilization Ratio at Enanta Pharmaceuticals came in at 0.20, up 23.3% from FY2024.
- In earlier fiscal years, Asset Utilization Ratio was 0.16 in FY2024 (-14.7%), 0.19 in FY2023 (-10.7%), 0.21 in FY2022 (+0.8%) and 0.21 in FY2021 (-16.4%).
- Quarterly Asset Utilization Ratio has moved between 0.17 (fiscal Q1 2024) and 0.24 (fiscal Q2 2023) over five years.
- Compared with a year earlier, Asset Utilization Ratio has increased for eight straight quarters, with growth averaging 13.5% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was fiscal Q4 2025 (growth of 28.7%); the worst was fiscal Q2 2024 (a decline of 28.1%).
- Per Business Quant data, ENTA's Asset Utilization Ratio in the three fiscal quarters before Q3 2026 was 0.21 (Q2 2026), 0.22 (Q1 2026) and 0.22 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Enanta Pharmaceuticals | 327.55 Mn | -400.44 Mn | - | 0.21 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.21 |
| Mar 31, 2026 | 0.21 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.19 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.24 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.23 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | 0.21 |
| Sep 30, 2021 | 0.22 |
API Access
Enanta Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();